thymine has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Established prostate cancer-derived cell lines LnCAP, DU-145, and PC-3 demonstrated NQO1 wild-type genotype." | 1.30 | 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. ( Borkowsi, M; Hillenbrand, M; Schuff-Werner, P; Seiter, H; Steiner, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steiner, M | 1 |
| Hillenbrand, M | 1 |
| Borkowsi, M | 1 |
| Seiter, H | 1 |
| Schuff-Werner, P | 1 |
1 other study available for thymine and Prostatic Hyperplasia
| Article | Year |
|---|---|
609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Topics: Adenocarcinoma; Alleles; Cytosine; Female; Genes, Neoplasm; Genotype; Humans; Male; NAD(P)H Dehydrog | 1999 |